$21.17
1.9410.09%
Last update: Oct 9, 6:15 PM
$20.81
1.588.23%
Scribe Therapeutics Inc
SCTXNASDAQ
Scribe Therapeutics (SCTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Sep 2, 2026 | $-2.62 | $-1.05 | -149.5 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Estimate | $-1.05 |
| Actual | $-2.62 |
| Surprise | -149.5% |
| Revenue | |
| Estimate | $3.1M |
| Actual | $1.9M |
| Surprise | -38.4% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.93 | $-0.40 | $-0.47 | $-0.55 |
| Revenue | ||||
| Consensus | $3.6M | $3.1M | — | — |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Sep 2, 2026 | $1.92M | $3.11M | -38.4 % |
